Topic: life sciences

The ten most exciting tools to hit the life sciences this year http://tinyurl.com/ycqwdcs

5 hours ago

Twitter | Topics: life... | Add twitter to your profile

hansonexperience posted a blog entry

Videoblog: uitreiking prijs "Meest innovatieve instelling 2009" aan de HAN
Vanmiddag kreeg de HAN en dan met name de Faculteit Techniek uit handen van Jeroen van der Veer, voorzitter van het Platform...

6 hours ago

Hans on Experience | Topics: Actualiteit, Filmpjes, HAN, autotechniek

hansonexperience posted new photos

HAN innovatiefste instelling van 2009 046

HAN innovatiefste instelling van 2009 045

HAN innovatiefste instelling van 2009 044

HAN innovatiefste instelling van 2009 043

HAN innovatiefste instelling van 2009 042

10 hours ago

Flickr | Topics: han, lifesciences, techniek, hogeschool... | Add flickr to your profile

Lowongan Kerja posted a blog entry

Clinical Trial Leader – Contract
Our client, is seeking a Clinical Trial Leader for their offices based in Switzerland on a contract role.JOB ROLE: ...

15 hours ago

Scholarship Database | Topics: Ireland, Jobs &..., United..., amp...

Xconomy posted a blog entry

Forma Gets a $25.5M Fix, Novartis Bids Idera Adieu, Alnylam CEO Talks Strategy, & More Boston-Area Life Sciences News
Somewhere between the turkey prep and the post-pie catatonia, folks at New England’s life sciences companies managed to...

21 hours ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston, Boston blog..., National blog..., Roundup

Xconomy posted a blog entry

Quick Take: Novartis Vaccine Chief Andrin Oswald on Swine Flu and Vaccine Business
It’s been a year since Andrin Oswald took over as CEO of Novartis Vaccines and Diagnostics, the 5th-largest vaccine...

24 hours ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston, Boston blog..., National blog..., Life Sciences

Xconomy posted a blog entry

Dyax Shares Rocket as FDA Clears Treatment for Rare Inflammatory Disease
Dyax got some good news late today that sent shares booming. The Cambridge, MA-based company (NASDAQ: DYAX) said it has...

1 day ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston, Boston blog..., National blog..., Biotech

Xconomy posted a blog entry

Santarus Shares Boom on FDA Approval of Over-the-Counter Heartburn Drug
San Diego-based Santarus (NASDAQ: SNTS) got some good news late today. The company’s partner, the Schering-Plough unit of...

1 day ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National blog..., San Diego, San Diego blog..., Biotech

Xconomy posted a blog entry

Tech Executive Pay Raises Way Down, New Study Says
Technology executive pay raises in 2009 have taken their biggest nosedive of the past decade, according to a new compensation...

2 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston blog..., National, National blog..., San Diego blog...

hansonexperience posted a blog entry

Videoblog: Reunie HAN HLO
Afgelopen zaterdag was de 1e reunie van HAN HLO en Veliant (de alumni vereniging). Ruim 200 belangstellenden waren aanwezig. De...

3 days ago

Hans on Experience | Topics: Actualiteit, Filmpjes, HAN, HAN

hansonexperience posted a blog entry

Fotoblog: Reunie HAN HLO
Afgelopen zaterdag was de 1e reunie van oud-studenten van de HAN Hogere Laboratorium Opleidingen. Hieronder een foto-impressie....

3 days ago

Hans on Experience | Topics: Actualiteit, Fotoblog, HAN, HAN

Xconomy posted a blog entry

Ekos, Enduring Tough Year for Devices, Sticks With Goal to Break Even Next Year
Ekos is on a quest to change the way doctors think about how to best dissolve blood clots. Like a lot of bold visions, this...

3 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National blog..., Seattle, Seattle blog..., Biotech

IanMcKendrick posted a tweet

A great audience tonight at rhe ERBI IT Special Interest Group seminar on Cloud Computing for life sciences. http://twitpic.com/r1zkw

6 days ago

Twitter | Topics: special interest..., life..., audience | Add twitter to your profile

Xconomy posted a blog entry

Enigma Names Top U.S. Execs
Enigma Diagnostics, the UK genetic diagnosis instrument maker that is setting up its U.S. shop in San Diego, today named Jorge...

7 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National..., San Diego, San Diego..., people

Xconomy posted a blog entry

Illumina OKs $100M Share Buyback
San Diego-based Illumina (NASDAQ: ILMN) said today that its board has authorized a program to buy back $100 million of stock....

8 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National..., San Diego, San Diego..., Biotech

Knowledge beyond words posted a tweet

RT @dullhunk: New blog post at O'Really? #swat4ls2009 Semantic Web Applications and Tools for the Life Sciences, (...) http://bit.ly/5YXwgs

9 days ago

Twitter | Topics: Semantic Web..., life..., RT, blog | Add twitter to your profile

Xconomy posted a blog entry

Under the Radar Deals: 10 (+1) New England October Financings You Never Heard About
The big picture is great. But at Xconomy, we also like the smaller details, which often fill in or round out the big...

10 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston, Boston blog..., National blog..., VC

Xconomy posted a blog entry

Ironwood Files to Go Public, Seeks to Raise as Much as $172.5M
Ironwood Pharmaceuticals is gearing up for the possibility of an IPO. The Cambridge, MA-based developer of a new treatment for...

12 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston, Boston blog..., National blog..., Biotech

Xconomy posted a blog entry

Blue Marble Snags $2M State Grant
Seattle-based Blue Marble Energy, the developer of renewable energy and specialty chemicals from biomass, said it has received...

12 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National..., Seattle, Seattle..., cleantech

Xconomy posted a blog entry

Biogen Idec Accused Again of Excessive CEO Pay, Lousy Performance, By Big Shareholder
[Update: 1:55 pm Eastern, 11/20/09] After a bitter standoff earlier this year with billionaire investor Carl Icahn over alleged...

12 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston, Boston blog..., National blog..., San Diego blog...

Xconomy posted a blog entry

$31.3M for Cambridgesoft
Cambridge, MA-based Cambridgesoft, which makes software for life sciences companies, disclosed in regulatory documents filed...

13 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston, Boston briefs, National..., IT

Xconomy posted a blog entry

Dendreon FDA Deadline Set For May 1
Seattle-based Dendreon (NASDAQ: DNDN), the developer of what it hopes will be the first FDA-approved treatment to actively...

13 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National..., Seattle, Seattle..., Biotech

emac posted a tweet

RBC Life Sciences Announces Third Quarter 2009 Results http://bit.ly/1dY8hw

13 days ago

Twitter | Topics: rbc, life... | Add twitter to your profile

Xconomy posted a blog entry

Beyond Anecdotes: Measuring Global Health Impact in Washington State
The threat of global infectious disease was already a significant humanitarian concern when Ken Stuart set up his independent...

14 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National Xcon, Seattle, Seattle Xcon, Biotech

Xconomy posted a blog entry

Genzyme Halts Development of New Kidney Drug; A “Very Significant” Bust, Analyst Says
Another day, another piece of bad news from Genzyme. The Cambridge, MA-based biotech giant (NASDAQ: GENZ) said today it is...

15 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston, Boston blog..., National blog..., Biotech

Xconomy posted a blog entry

Trubion CEO Peter Thompson Steps Down, Arch’s Gillis To Step Up Temporarily
[Updated: 5:55 pm Pacific, 11/16/09] Trubion Pharmaceuticals, the Seattle-based company developing new drugs for autoimmune...

16 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National blog..., Seattle, Seattle blog..., Biotech

Xconomy posted a blog entry

Fate Therapeutics Bags $30M Venture Deal, Led by OVP, to Develop “Industrialized” Stem Cells
Fate Therapeutics, the San Diego-based company on a quest to develop techniques that make stem cell research practical for the...

17 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston blog..., National, National blog..., San Diego blog...

Xconomy posted a blog entry

Cadence Hit By FDA Delay
San Diego-based Cadence Pharmaceuticals (NASDAQ: CADX) said today that the FDA has pushed back its deadline for reviewing the...

19 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National..., San Diego, San Diego..., Biotech

Xconomy posted a blog entry

Trius Therapeutics Reveals Plans for IPO, SpectraScience Raises $4.3M, Sequenom Tightens its Belt, & More San Diego Life Sciences News
Some San Diego life sciences companies reported a burst of new financing, while embattled Sequenom told investors it’s trying...

21 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National blog..., San Diego, San Diego blog..., Roundup

Xconomy posted a blog entry

Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News
This was the week that a little biotech company in Bothell that few of the locals have ever heard of, burst onto the national...

21 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National blog..., Seattle, Seattle blog..., Roundup

Xconomy posted a blog entry

Aileron’s New Class of Drugs Shown to Get Inside Cells to Block Prime Cancer Target
Cambridge, MA-based Aileron Therapeutics has bet the company on the idea that it has discovered a whole new class of drugs...

21 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston, Boston blog..., National blog..., Biotech

Xconomy posted a blog entry

Pulmatrix Pulls in $30.2M, GenArts Gobbles Up Wondertouch, BioVex Bags $30M, & More Boston-Area Deals News
Several of New England’s tech and life sciences firms got juicy deals the past week and a half.—Boston’s...

22 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston, Boston blog..., National blog..., Roundup

Xconomy posted a blog entry

Alder and New Partner, Bristol, to Give Amgen and Abbott a Run for Their Money
Alder Biopharmaceuticals keeps such a low profile that even after five years in business, few people in Seattle biotech know...

22 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National blog..., Seattle, Seattle blog..., Biotech

Xconomy posted a blog entry

Right Brains Wanted: Sanofi-Aventis Wants to Tap the Creative Genius of Boston-Area Biotechs
Sanofi-Aventis (NYSE: SNY) hosted a large event at its R&D site in Cambridge, MA, yesterday to make its pitch for why...

22 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston, Boston blog..., National blog..., Life Sciences